Skip to main content

Table 1 List of abbreviations

From: RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives

BRCA1

Breast cancer susceptibility gene 1

BRCA2

Breast cancer susceptibility gene 2

CRAd

Conditionally replicating adenovirus

DMBA

7,14-dimethylbenz[a]anthracene

EGF

Epidermal growth factor

EGFR

Epidermal growth factor receptor

ELISA

Enzyme-linked immunosorbent assay

EMT

Epithelial-mesenchymal transition

ER

Estrogen receptor

ErbB

Epidermal growth factor receptor

ErbB2

Epidermal growth factor receptor 2

HRT

Hormone replacement therapy

Id2

Inhibitor of DNA binding protein 2

IkB

Inhibitor of kappa B

IkBα

Inhibitor of kappa Bα

IKK-α

Inhibitor-kB kinase-α

IgG

Immunoglobulin G

IHC methods

Immunohistochemical methods

IL-1

Interleukin-1

IL-6

Interleukin-6

IL-8

Interleukin-8

Jak2

Janus kinase 2

LECs

Luminal epithelial cells

MaSCs

Mammary stem cells

M-CSF

Macrophage colony-stimulating factor

MECs

Myoepithelial cells

MMTV

Mouse mammary tumor virus

MPA

Medroxyprogesterone acetate

NF-kB

Nuclear factor-kB

OPG

Osteoprotegerin

PCR

Polymerase chain reaction

PR

Progesterone receptor

PRLR

Prolactin receptor

PTHrP

Parathyroid hormone-related protein

RANK

Receptor activator of NF-kB

RANKL

Receptor activator of NF-kB-ligand

SREs

Skeletal-related events

STAT5a

Signal transducer and activator of transcription 5a

TGF-β

Transforming growth factor-β

TNBC

Triple-negative breast cancer

TNF

Tumor necrosis factor

TNFR

Tumor necrosis factor receptor

TNFRSF11A

TNF Receptor Superfamily Member 11a

TNF-α

Tumor necrosis factor-α

TRAF

TNF receptor-associated factor

TRAF2

TNF receptor-associated factor-2

TRAIL

TNF related apoptosis-inducing ligand

TRANCE

TNF-related activation-induced cytokine